CARLOMAGNO, FRANCESCA
CARLOMAGNO, FRANCESCA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer.
2006 Santoro, Massimo; Carlomagno, Francesca
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
2002 F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase.
2003 Andreozzi, F; Melillo, ROSA MARINA; Carlomagno, F; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, M; Formisano, P.
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases
2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Ciardiello, Fortunato; Tortora, Giampaolo; Vecchio, Giancarlo; Ryan, A. J.; Fontanini, G.; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).
2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes
2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati
2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi.
2007 Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE
1992 Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
1998 Carlomagno, F.; Melillo, ROSA MARINA; Visconti, R.; Salvatore, G.; DE VITA, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Activation of RET oncogene and thyroid carcinogenesis
1993 Santoro, Massimo; Grieco, M.; Melillo, ROSA MARINA; Carlomagno, F.; Cerrato, A.; Sabino, N.; Battaglia, C.; Fusco, Alfredo; Vecchio, Giancarlo
RET\PTC activation in human thyroid carcinomas
1995 Fusco, Alfredo; Santoro, Massimo; Grieco, M.; Carlomagno, Francesca; Dathan, N.; Fabien, N.; Berlingieri, M. T.; Li, Z.; de franciscis, V.; Salvatore, Domenico; Melillo, ROSA MARINA; Portella, Giuseppe; Cerrato, A.; Colantuoni, V.; Vecchio, Giancarlo
Molecular Mechianism of RET Activation In Human Neoplasia
2002 Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo
Molecular mechanisms of RET activation in human cancer.
2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo
Attacking cancer with molecularly targeted agents
2013 Santoro, Massimo; Carlomagno, Francesca
Oncogenic rearrangements driving ionizing radiation-associated human cancer
2013 Santoro, Massimo; Carlomagno, Francesca
Structure prediction and validation of the ERK8 kinase domain.
2013 Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, Francesca; Botta, M; Chiariello, M.
NCOA4 inhibits initiation of DNA replication to maintain genome stability
2012 Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Molecular targeting of the RET kinase in thyroid cancer
2007 Santoro, Massimo; Carlomagno, F.
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. | 1.1 Articolo in rivista | 2006 | Santoro, Massimo; Carlomagno, Francesca | |
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma | 1.1 Articolo in rivista | 2002 | F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo | |
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. | 1.1 Articolo in rivista | 2003 | Andreozzi, F; Melillo, ROSA MARINA; Carlomagno, F; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, M; Formisano, P. | |
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases | 1.1 Articolo in rivista | 2002 | Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Ciardiello, Fortunato; Tortora, Giampaolo; Vecchio, Giancarlo; Ryan, A. J.; Fontanini, G.; Fusco, Alfredo; Santoro, Massimo | |
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). | 1.1 Articolo in rivista | 2003 | Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo | |
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes | 1.1 Articolo in rivista | 2002 | Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo | |
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. | 1.1 Articolo in rivista | 2001 | Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo | |
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati | 3.1 Monografia o trattato scientifico | 2009 | Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo | |
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi. | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo | |
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE | 1.1 Articolo in rivista | 1992 | Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo | |
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease | 1.1 Articolo in rivista | 1998 | Carlomagno, F.; Melillo, ROSA MARINA; Visconti, R.; Salvatore, G.; DE VITA, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M. | |
Activation of RET oncogene and thyroid carcinogenesis | 2.1 Contributo in volume (Capitolo o Saggio) | 1993 | Santoro, Massimo; Grieco, M.; Melillo, ROSA MARINA; Carlomagno, F.; Cerrato, A.; Sabino, N.; Battaglia, C.; Fusco, Alfredo; Vecchio, Giancarlo | |
RET\PTC activation in human thyroid carcinomas | 1.1 Articolo in rivista | 1995 | Fusco, Alfredo; Santoro, Massimo; Grieco, M.; Carlomagno, Francesca; Dathan, N.; Fabien, N.; Berlingieri, M. T.; Li, Z.; de franciscis, V.; Salvatore, Domenico; Melillo, ROSA MARINA; Portella, Giuseppe; Cerrato, A.; Colantuoni, V.; Vecchio, Giancarlo | |
Molecular Mechianism of RET Activation In Human Neoplasia | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo | |
Molecular mechanisms of RET activation in human cancer. | 1.1 Articolo in rivista | 2002 | Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo | |
Attacking cancer with molecularly targeted agents | 1.1 Articolo in rivista | 2013 | Santoro, Massimo; Carlomagno, Francesca | |
Oncogenic rearrangements driving ionizing radiation-associated human cancer | 1.1 Articolo in rivista | 2013 | Santoro, Massimo; Carlomagno, Francesca | |
Structure prediction and validation of the ERK8 kinase domain. | 1.1 Articolo in rivista | 2013 | Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, Francesca; Botta, M; Chiariello, M. | |
NCOA4 inhibits initiation of DNA replication to maintain genome stability | 4.2 Abstract in Atti di convegno | 2012 | Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca | |
Molecular targeting of the RET kinase in thyroid cancer | 8.02 Comunicazioni a Convegni o Seminari | 2007 | Santoro, Massimo; Carlomagno, F. |